Percutaneous Unilateral Biportal Endoscopy Versus Uniportal Endoscopy for Lumbar Spinal Stenosis: Study Protocol
1 other identifier
observational
120
1 country
1
Brief Summary
A prospective study aimed to compare the efficacy and safety of Unilateral biportal endoscopic (UBE) technique and uniportal endoscopic (UE) technique for treating patients with lumbar spinal stenosis (LSS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 7, 2024
CompletedFirst Posted
Study publicly available on registry
April 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 2, 2025
April 1, 2025
2 years
April 7, 2024
June 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Oswestry Disability Index (ODI)
0-100%, the higher the score, the more severe the lumbar spine dysfunction
From enrollment to the end of follow-up at 1 year
Secondary Outcomes (24)
Magnetic resonance imaging (MRI)
From enrollment to the follow-up at 2 weeks
Computed tomography (CT) scans
From enrollment to the end of follow-up at 2 weeks
Creatine kinase (CK)
From enrollment to the end of follow-up at 2 weeks
Erythrocyte sedimentation rate (ESR)
From enrollment to the follow-up at 2 weeks
Surgical complication
From enrollment to the end of follow-up at 1 year
- +19 more secondary outcomes
Study Arms (2)
UBE Group
Patients with LSS undergoing UBE
UE Group
Patients with LSS undergoing UE
Eligibility Criteria
Patients with LSS undergoing UBE or UE decompression performed by two experienced spine surgeons at the same hospital will be recruited for the study.
You may qualify if:
- Age range: 50-80 years
- Diagnosed with LSS of 1-2 response levels
- The predominant manifestation is neurogenic intermittent claudication, and conservative treatment has been ineffective for at least 3 months
- Degenerative lumbar spondylolisthesis of less than I degree or without spine instability
- Patients agree to participate in the study and are willing to complete the follow-up
You may not qualify if:
- Isthmic lumbar spondylolisthesis or degenerative lumbar spondylolisthesis of greater than I degree
- Instability at the response level
- Prior surgical history at the response level
- Scoliosis with Cobb angle \>20 degrees
- Other conditions affecting the lumbar spine (infection, tumor, fracture, neurological diseases, and others)
- Patients with medical disorders who are unable to tolerate surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Friendship Hospital
Beijing, Beijing Municipality, 100050, China
Related Publications (1)
Tan H, Liu Y, Li G, Yu L, Yang Y, Lo Y, Bin Z, Li X. Percutaneous unilateral biportal endoscopy versus uniportal endoscopy for lumbar spinal stenosis: a single-centre, prospective, non-randomised cohort trial protocol. BMJ Open. 2025 Jul 25;15(7):e087863. doi: 10.1136/bmjopen-2024-087863.
PMID: 40713043DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2024
First Posted
April 15, 2024
Study Start
January 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 2, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share